The Cigna Group (NYSE:CI) Shares Bought by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. boosted its position in shares of The Cigna Group (NYSE:CI – Get Rating) by 43.2% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 7,883 shares of the health services provider’s stock after acquiring an additional 2,377 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in The Cigna Group were worth $2,188,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Hexagon Capital Partners LLC raised its stake in shares of The Cigna Group by 178.4% during the 3rd quarter. Hexagon Capital Partners LLC now owns 103 shares of the health services provider’s stock valued at $29,000 after buying an additional 66 shares during the last quarter. Householder Group Estate & Retirement Specialist LLC purchased a new position in shares of The Cigna Group during the 3rd quarter valued at about $34,000. Wagner Wealth Management LLC purchased a new position in shares of The Cigna Group during the 2nd quarter valued at about $35,000. Pittenger & Anderson Inc. raised its stake in shares of The Cigna Group by 40.0% during the 3rd quarter. Pittenger & Anderson Inc. now owns 140 shares of the health services provider’s stock valued at $39,000 after buying an additional 40 shares during the last quarter. Finally, BDO Wealth Advisors LLC increased its stake in shares of The Cigna Group by 154.0% in the 3rd quarter. BDO Wealth Advisors LLC now owns 160 shares of the health services provider’s stock valued at $44,000 after purchasing an additional 97 shares in the last quarter. Institutional investors and hedge funds own 87.61% of the company’s stock.

Insider Activity at The Cigna Group

In other The Cigna Group news, insider Michael W. Triplett sold 1,731 shares of the business’s stock in a transaction that occurred on Friday, March 10th. The stock was sold at an average price of $271.67, for a total value of $470,260.77. Following the sale, the insider now owns 30,235 shares of the company’s stock, valued at $8,213,942.45. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other The Cigna Group news, insider Michael W. Triplett sold 1,731 shares of the business’s stock in a transaction that occurred on Friday, March 10th. The stock was sold at an average price of $271.67, for a total value of $470,260.77. Following the sale, the insider now owns 30,235 shares of the company’s stock, valued at $8,213,942.45. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO David Cordani sold 20,148 shares of the business’s stock in a transaction that occurred on Monday, February 27th. The shares were sold at an average price of $294.06, for a total value of $5,924,720.88. Following the completion of the sale, the chief executive officer now directly owns 120,496 shares in the company, valued at approximately $35,433,053.76. The disclosure for this sale can be found here. Over the last three months, insiders have sold 27,752 shares of company stock worth $8,008,479. Insiders own 0.80% of the company’s stock.

The Cigna Group Trading Down 1.8 %

CI opened at $269.45 on Friday. The Cigna Group has a one year low of $238.48 and a one year high of $340.11. The stock has a market capitalization of $80.04 billion, a PE ratio of 12.60, a P/E/G ratio of 0.98 and a beta of 0.67. The business’s 50 day moving average price is $296.46 and its 200 day moving average price is $304.42. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.70 and a current ratio of 0.70.

The Cigna Group (NYSE:CI – Get Rating) last released its quarterly earnings data on Friday, February 3rd. The health services provider reported $4.96 EPS for the quarter, beating analysts’ consensus estimates of $4.84 by $0.12. The Cigna Group had a return on equity of 16.01% and a net margin of 3.69%. The firm had revenue of $45.75 billion for the quarter, compared to analysts’ expectations of $45.79 billion. During the same period in the prior year, the firm posted $4.77 earnings per share. The firm’s quarterly revenue was up .1% on a year-over-year basis. As a group, equities research analysts expect that The Cigna Group will post 24.65 EPS for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 23rd. Investors of record on Wednesday, March 8th will be issued a $1.23 dividend. The ex-dividend date of this dividend is Tuesday, March 7th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.12. This represents a $4.92 dividend on an annualized basis and a yield of 1.83%. The Cigna Group’s dividend payout ratio is currently 23.01%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Wells Fargo & Company lowered The Cigna Group from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $370.00 to $355.00 in a research note on Tuesday, January 3rd. Deutsche Bank Aktiengesellschaft cut their price target on The Cigna Group from $359.00 to $348.00 in a research note on Wednesday, February 8th. SVB Leerink lifted their price target on The Cigna Group from $309.00 to $335.00 and gave the company a “market perform” rating in a research note on Wednesday, February 8th. Raymond James cut their price target on The Cigna Group from $370.00 to $350.00 and set an “outperform” rating for the company in a research note on Tuesday, February 7th. Finally, Morgan Stanley lifted their price target on The Cigna Group from $347.00 to $365.00 and gave the company an “overweight” rating in a research note on Friday, January 6th. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $339.00.

The Cigna Group Profile

(Get Rating)

The Cigna Group is engaged in the provision of global health services. It operates through the following segments: Evernorth, U.S. Medical, International Markets, and Group Disability and Other. The Evernorth segment includes a broad range of coordinated and point solution health services, including pharmacy solutions, benefits management solutions, care solutions and intelligence solutions.